Short-Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared with Standard of Care (SAVE): A Randomized Clinical Trial Pancreatic ductal adenocarcinoma (PDAC) is the third ...
Results Underscore PRP Candidacy as a Disruptor of the Tumor MicroenvironmentMELBOURNE, Australia, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”) ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University of Cincinnati Cancer Center researchers examined the unique tumor ...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, primarily due to its dense, desmoplastic and immunosuppressive tumor microenvironment (TME) that hinders the efficacy of ...
Cancer cells and tumors do not exist in a vacuum. Far from the isolation and self-sufficiency of the fictional Wakanda, tumors develop in and alter the nearby milieu of immune cells, connective tissue ...
Cosimo Commisso, PhD, is the interim director and deputy director of the NCI-Designated Cancer Center at Sanford Burnham Prebys, and the senior and corresponding author of the manuscript. Cancer cells ...
Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback